Tg Therapeutics Inc (TGTX)

EBITDA

$21.77M

Quarterly · Period ending: · USD

TGTX logo

TGTX EBITDA

Latest reported$21.77M
TGTX Quarterly EBITDA ($100.00K → $21.77M)
High-resolution chart · PNG

TGTX ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
21,770,000
28,109,000
51,693,000
32,692,000
37,695,000
12,281,000
32,576,000
15,164,000
10,600,000
-8,308,000
-11,503,000
117,769,000
-43,898,000
-36,267,000
-50,006,000
-34,041,000
-37,362,000
-66,220,000
-92,126,000
-84,470,000
-76,753,000
-88,618,000
-86,821,000
-85,459,000
-50,566,000
-49,831,000
-37,600,000
-60,321,000
-35,113,000
-34,359,000
-54,126,000
-33,928,000
-44,121,000
-41,557,000
-31,015,000
-31,564,000
-28,404,000
-27,646,000
-23,442,266
-24,906,326
-16,006,504
-13,985,776
-17,634,875
-13,404,868
-16,853,271
-14,600,432
-18,719,647
-17,438,450
-11,954,645
-7,320,203
-5,177,673
-4,315,340
-6,628,571
-3,442,024
-2,585,772
-2,481,616
0
-17,176,389
-3,062,965
-29,879
-297,000
-5,253,251
-445,812
-1,345,535
-523,504
-528,649
-340,087
-394,406
-475,773
-555,760
55,101
-1,375,931
-1,459,547
-1,606,219
-1,910,817
-2,696,589
-4,909,912
-2,578,294
-3,164,592
-1,950,351
-2,342,664
-2,482,534
-14,514,198
-1,861,627
-1,487,702
-1,424,372
-1,750,127
-2,202,995
-951,578
-1,109,979
-1,518,343
-1,989,716
-680,839
-380,209
-354,019
-575,214
-248,799
-618,385
-546,982
-693,415
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.